Early Weight Loss and Other Factors Associated With Clinically Significant Weight Loss in Two Commercial Weight Loss Programmes [0.03%]
早期减重及其他与两种商业减肥项目中具有临床意义的减重相关的因素
Christopher D Coleman,Jessica R Kiel,Orsolya M Palacios et al.
Christopher D Coleman et al.
This secondary analysis assessed potential factors associated with achieving ≥ 5% or ≥ 10% weight loss among adults in a clinical trial evaluating two commercial weight loss programmes. Participants [n = 124, 45.7 (13.1) years, 20.2% male...
Variation in the Commissioning of Semaglutide for the Treatment of Obesity and Overweight Across England: Results of Three Freedom of Information-Based Mapping Exercises Across the 42 Integrated Care Boards of England [0.03%]
基于英格兰42个综合护理委员会的三次信息自由-based调查结果：英格兰各地塞马鲁肽治疗肥胖和超重的委托情况差异性调查结果
Anne de Bray,Hanna Schnitzer,Elisabeth Mahase et al.
Anne de Bray et al.
Obesity medications are recommended in England with legislation necessitating their availability. However, given the number of people who meet clinically approved eligibility criteria, funding these medications and associated support servic...
Beyond BMI: Practical Guide for Clinicians to Integrate the Lancet Commission's Obesity Framework and King's Obesity Staging System [0.03%]
超越BMI：临床医生实用指南，融合《柳叶刀》委员会肥胖框架和国王学院肥胖分期系统
Tak Ying Louise Ko,Alexander D Miras,Dimitri J Pournaras et al.
Tak Ying Louise Ko et al.
Body mass index (BMI) on its own is a poor diagnostic and staging tool for obesity because it does not measure health status. The newly published Lancet Clinical Obesity Criteria (LCOC) for defining clinical obesity distinguish preclinical ...
Measuring and Managing Obesity in Pregnancy Using the Edmonton Obesity Staging System: A Scoping Review [0.03%]
利用埃德蒙顿肥胖分期系统测量和管理妊娠期肥胖的循证研究：综述性文章
Taniya S Nagpal,Jordyn M Cox,Ximena Ramos Salas et al.
Taniya S Nagpal et al.
Emerging evidence and clinical practice guidelines have highlighted that obesity, defined as a chronic disease characterised by excess or dysfunctional adipose tissue, may not be accurately measured or understood by solely relying on body m...
Ahmed Ibrahim,Don C Rockey
Ahmed Ibrahim
Given the potential for more rapid ethanol absorption in patients who have undergone bariatric surgery, we hypothesized that bariatric surgery is associated with risk for more severe alcohol-related liver disease. Therefore, patients ≥ 18 ...
Effect of Tirzepatide on the Risk of Developing Type 2 Diabetes Mellitus Among the People Living With Obesity or Overweight: A Systematic Review [0.03%]
tirzepatide对肥胖或超重人群发生2型糖尿病风险的影响:系统评价
Geeta Pardeshi,Uddhav T Kumbhar,Mogan Kaviprawin et al.
Geeta Pardeshi et al.
Tirzepatide provides superior efficacy in weight reduction and metabolic control compared to existing therapies. The present systematic review assessed the effect of Tirzepatide on the risk of developing type 2 diabetes mellitus (T2DM) amon...
H M Parretti,S E Erskine,K D Coulman et al.
H M Parretti et al.
This review highlights the important role primary care plays in obesity management, using England as an example. It includes a comprehensive summary of current management and referral options for primary care clinicians, a discussion of the...
Commissioning of Tier 3 Obesity Services by Integrated Care Boards in England: An Analysis of Responses to Freedom of Information Requests [0.03%]
英格兰联合护理委员会委托第3级肥胖服务：信息自由请求回复分析
Nicholas Finer,Nikolaos Fragkas,Alexander Dimitri Miras et al.
Nicholas Finer et al.
This research surveyed Tier 3 (specialist, multidisciplinary) adult weight management services in England commissioned for the National Health Service (NHS) by Integrated Care Boards (ICBs) across England in financial year 2022-2023. A surv...
Do Obesity Classifications Create the Obesity Paradox? A Scoping Review of Obesity Definitions Applied in Sepsis Research [0.03%]
肥胖分类会造成本质性肥胖悖论吗？系统梳理脓毒症研究中应用的肥胖定义
Efris Kartikasari,Brian Robinson,Caz Hales
Efris Kartikasari
Obesity appears to be associated with improved health outcomes in patients with sepsis, a phenomenon termed the obesity paradox. However, the potential influence of varying operational definitions of obesity on clinical outcomes within this...
IMPROVE 2023: The 2nd International Meeting on Pathway-Related Obesity: Vision & Evidence [0.03%]
2023年国际代谢与肥胖症路径关系会议：愿景和证据
Karine Clément,Erica L T van den Akker,Jesús Argente et al.
Karine Clément et al.
A total of 150 clinicians and researchers representing 19 countries came together in person and online to participate in the highly anticipated 2nd International Meeting on Pathway-Related Obesity: Vision & Evidence (IMPROVE), held on 13-15...